{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:28:40Z","timestamp":1793831320653,"version":"4.6.1"},"reference-count":161,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T00:00:00Z","timestamp":1589328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autophagy is a lysosome-dependent intracellular degradative pathway, which mediates the cellular adaptation to nutrient and oxygen depletion as well as to oxidative and endoplasmic reticulum stress. The molecular mechanisms that stimulate autophagy include the activation of energy deprivation sensors, sirtuin-1 (SIRT1) and adenosine monophosphate-activated protein kinase (AMPK). These enzymes not only promote organellar integrity directly, but they also enhance autophagic flux, which leads to the removal of dysfunctional mitochondria and peroxisomes. Type 2 diabetes is characterized by suppression of SIRT1 and AMPK signaling as well as an impairment of autophagy; these derangements contribute to an increase in oxidative stress and the development of cardiomyopathy. Antihyperglycemic drugs that signal through insulin may further suppress autophagy and worsen heart failure. In contrast, metformin and SGLT2 inhibitors activate SIRT1 and\/or AMPK and promote autophagic flux to varying degrees in cardiomyocytes, which may explain their benefits in experimental cardiomyopathy. However, metformin and SGLT2 inhibitors differ meaningfully in the molecular mechanisms that underlie their effects on the heart. Whereas metformin primarily acts as an agonist of AMPK, SGLT2 inhibitors induce a fasting-like state that is accompanied by ketogenesis, a biomarker of enhanced SIRT1 signaling. Preferential SIRT1 activation may also explain the ability of SGLT2 inhibitors to stimulate erythropoiesis and reduce uric acid (a biomarker of oxidative stress)\u2014effects that are not seen with metformin. Changes in both hematocrit and serum urate are the most important predictors of the ability of SGLT2 inhibitors to reduce the risk of cardiovascular death and hospitalization for heart failure in large-scale trials. Metformin and SGLT2 inhibitors may also differ in their ability to mitigate diabetes-related increases in intracellular sodium concentration and its adverse effects on mitochondrial functional integrity. Differences in the actions of SGLT2 inhibitors and metformin may reflect the distinctive molecular pathways that explain differences in the cardioprotective effects of these drugs.<\/jats:p>","DOI":"10.1186\/s12933-020-01041-4","type":"journal-article","created":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T16:06:31Z","timestamp":1589385991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":97,"title":["Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-2387","authenticated-orcid":false,"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,13]]},"reference":[{"key":"1041_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cell.2018.09.048","volume":"176","author":"B Levine","year":"2019","unstructured":"Levine B, Kroemer G. Biological functions of\u00a0autophagy\u00a0genes: a disease perspective. Cell. 2019;176:11\u201342.","journal-title":"Cell"},{"key":"1041_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1172\/JCI73938","volume":"125","author":"B Levine","year":"2015","unstructured":"Levine B, Packer M, Codogno P. Development of\u00a0autophagy\u00a0inducers in clinical medicine. J Clin Invest. 2015;125:14\u201324.","journal-title":"J Clin Invest."},{"issue":"7","key":"1041_CR3","doi-asserted-by":"publisher","first-page":"e45595","DOI":"10.15252\/embr.201745595","volume":"19","author":"E Marcassa","year":"2018","unstructured":"Marcassa E, Kallinos A, Jardine J, Rusilowicz-Jones EV, Martinez A, Kuehl S, Islinger M, Clague MJ, Urb\u00e9 S. Dual role of USP30 in controlling basal\u00a0pexophagy\u00a0and\u00a0mitophagy. EMBO Rep. 2018;19(7):e45595. https:\/\/doi.org\/10.15252\/embr.201745595.","journal-title":"EMBO Rep"},{"key":"1041_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nature14498","volume":"522","author":"A Khaminets","year":"2015","unstructured":"Khaminets A, Heinrich T, Mari M, Grumati P, Huebner AK, Akutsu M, Liebmann L, Stolz A, Nietzsche S, Koch N, Mauthe M, Katona I, Qualmann B, Weis J, Reggiori F, Kurth I, H\u00fcbner CA, Dikic I. Regulation of\u00a0endoplasmic\u00a0reticulum turnover by selective\u00a0autophagy. Nature. 2015;522:354\u20138.","journal-title":"Nature"},{"key":"1041_CR5","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/s41556-018-0235-8","volume":"20","author":"AM Leidal","year":"2018","unstructured":"Leidal AM, Levine B, Debnath J. Autophagy\u00a0and the cell biology of age-related disease. Nat Cell Biol. 2018;20:1338\u201348.","journal-title":"Nat Cell Biol"},{"key":"1041_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41580-018-0033-y","volume":"19","author":"M Hansen","year":"2018","unstructured":"Hansen M, Rubinsztein DC, Walker DW. Autophagy\u00a0as a promoter of\u00a0longevity: insights from model organisms. Nat Rev Mol Cell Biol. 2018;19:579\u201393.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1041_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.18632\/aging.100183","volume":"2","author":"E Panieri","year":"2010","unstructured":"Panieri E, Toietta G, Mele M, Labate V, Ranieri SC, Fusco S, Tesori V, Antonini A, Maulucci G, De Spirito M, Galeotti T, Pani G. Nutrient\u00a0withdrawal rescues growth factor-deprived cells from mTOR-dependent damage. Aging (Albany NY). 2010;2:487\u2013503.","journal-title":"Aging (Albany NY)."},{"key":"1041_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molmed.2010.09.005","volume":"17","author":"MP Gillum","year":"2011","unstructured":"Gillum MP, Erion DM, Shulman GI. Sirtuin-1\u00a0regulation of mammalian metabolism. Trends Mol Med. 2011;17:8\u201313. https:\/\/doi.org\/10.1016\/j.molmed.2010.09.005.","journal-title":"Trends Mol Med."},{"key":"1041_CR9","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature. 2005;434:113\u20138.","journal-title":"Nature"},{"key":"1041_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrm3311","volume":"13","author":"DG Hardie","year":"2012","unstructured":"Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and\u00a0energy\u00a0sensor\u00a0that maintains\u00a0energy\u00a0homeostasis. Nat Rev Mol Cell Biol. 2012;13:251\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1041_CR11","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1128\/MCB.23.24.9361-9374.2003","volume":"23","author":"CJ Hu","year":"2003","unstructured":"Hu CJ, Wang LY, Chodosh LA, Keith B, Simon MC. Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and\u00a0HIF-2alpha\u00a0in hypoxic gene regulation. Mol Cell Biol. 2003;23:9361\u201374.","journal-title":"Mol Cell Biol"},{"key":"1041_CR12","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/db12-0533","volume":"62","author":"C He","year":"2013","unstructured":"He C, Zhu H, Li H, Zou MH, Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated\u00a0AMPK\u00a0enhances cardiac\u00a0autophagy\u00a0and protects against cardiomyocyte apoptosis in diabetes. Diabetes. 2013;62:1270\u201381.","journal-title":"Diabetes"},{"key":"1041_CR13","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1111\/jcmm.12312","volume":"18","author":"B Wang","year":"2014","unstructured":"Wang B, Yang Q, Sun YY, Xing YF, Wang YB, Lu XT, Bai WW, Liu XQ, Zhao YX. Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice. J Cell Mol Med. 2014;18:1599\u2013611.","journal-title":"J Cell Mol Med"},{"key":"1041_CR14","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3892\/etm.2016.3190","volume":"11","author":"L Gui","year":"2016","unstructured":"Gui L, Liu B, Lv G. Hypoxia induces autophagy in cardiomyocytes via a hypoxia-inducible factor 1-dependent mechanism. Exp Ther Med. 2016;11:2233\u20139.","journal-title":"Exp Ther Med."},{"issue":"2018","key":"1041_CR15","doi-asserted-by":"publisher","first-page":"5786742","DOI":"10.1155\/2018\/5786742","volume":"16","author":"A Gyongyosi","year":"2018","unstructured":"Gyongyosi A, Terraneo L, Bianciardi P, Tosaki A, Lekli I, Samaja M. The impact of moderate chronic hypoxia and hyperoxia on the level of apoptotic and autophagic proteins in myocardial tissue. Oxid Med Cell Longev. 2018;16(2018):5786742. https:\/\/doi.org\/10.1155\/2018\/5786742.","journal-title":"Oxid Med Cell Longev."},{"key":"1041_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s12031-018-1162-7","volume":"66","author":"N Lu","year":"2018","unstructured":"Lu N, Li X, Tan R, An J, Cai Z, Hu X, Wang F, Wang H, Lu C, Lu H. HIF-1\u03b1\/Beclin1-mediated\u00a0autophagy\u00a0is involved in neuroprotection induced by hypoxic preconditioning. J Mol Neurosci. 2018;66:238\u201350.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"1041_CR17","doi-asserted-by":"publisher","first-page":"12637","DOI":"10.1038\/s41598-018-30977-7","volume":"8","author":"M Jang","year":"2018","unstructured":"Jang M, Park R, Kim H, Namkoong S, Jo D, Huh YH, Jang IS, Lee JI, Park J. AMPK\u00a0contributes to autophagosome maturation and lysosomal fusion. Sci Rep. 2018;8(1):12637. https:\/\/doi.org\/10.1038\/s41598-018-30977-7.","journal-title":"Sci Rep."},{"key":"1041_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cell.2014.03.026","volume":"157","author":"EF Fang","year":"2014","unstructured":"Fang EF, Scheibye-Knudsen M, Brace LE, Kassahun H, SenGupta T, Nilsen H, Mitchell JR, Croteau DL, Bohr VA. Defective\u00a0mitophagy\u00a0in XPA via PARP-1 hyperactivation and NAD(+)\/SIRT1\u00a0reduction. Cell. 2014;157:882\u201396.","journal-title":"Cell"},{"key":"1041_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cmet.2014.09.017","volume":"20","author":"KM Walter","year":"2014","unstructured":"Walter KM, Sch\u00f6nenberger MJ, Tr\u00f6tzm\u00fcller M, Horn M, Els\u00e4sser HP, Moser AB, Lucas MS, Schwarz T, Gerber PA, Faust PL, Moch H, K\u00f6feler HC, Krek W, Kovacs WJ. Hif-2\u03b1 promotes degradation of mam-malian peroxisomes by\u00a0selective\u00a0autophagy. Cell Metab. 2014;20:882\u201397.","journal-title":"Cell Metab"},{"key":"1041_CR20","doi-asserted-by":"publisher","first-page":"30800","DOI":"10.1074\/jbc.M111.244780","volume":"287","author":"R Chen","year":"2012","unstructured":"Chen R, Xu M, Hogg RT, Li J, Little B, Gerard RD, Garcia JA. The acetylase\/deacetylase couple CREB-binding protein\/Sirtuin 1\u00a0controls hypoxia-inducible factor 2 signaling. J Biol Chem. 2012;287:30800\u201311.","journal-title":"J Biol Chem"},{"key":"1041_CR21","doi-asserted-by":"publisher","first-page":"13869","DOI":"10.1074\/jbc.M110.175414","volume":"286","author":"R Chen","year":"2011","unstructured":"Chen R, Dioum EM, Hogg RT, Gerard RD, Garcia JA. Hypoxia increases\u00a0sirtuin 1\u00a0expression in a hypoxia-inducible factor-dependent manner. J Biol Chem. 2011;286:13869\u201378.","journal-title":"J Biol Chem"},{"key":"1041_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1041_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL. Sirt1\u00a0and the\u00a0mitochondria. Mol Cells. 2016;39:87\u201395.","journal-title":"Mol Cells"},{"issue":"884\u2013896","key":"1041_CR24","first-page":"e5","volume":"26","author":"HJ Weir","year":"2017","unstructured":"Weir HJ, Yao P, Huynh FK, Escoubas CC, Goncalves RL, Burkewitz K, Laboy R, Hirschey MD, Mair WB. Dietary restriction and\u00a0AMPK\u00a0increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab. 2017;26(884\u2013896):e5.","journal-title":"Cell Metab"},{"key":"1041_CR25","doi-asserted-by":"publisher","first-page":"13045","DOI":"10.1074\/jbc.M109.067728","volume":"285","author":"K Hasegawa","year":"2010","unstructured":"Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Sueyasu K, Washida N, Tokuyama H, Tzukerman M, Skorecki K, Hayashi K, Itoh H. Kidney-specific overexpression of\u00a0Sirt1\u00a0protects against acute kidney injury by retaining peroxisome function. J Biol Chem. 2010;285:13045\u201356.","journal-title":"J Biol Chem"},{"key":"1041_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbrc.2008.04.176","volume":"372","author":"K Hasegawa","year":"2008","unstructured":"Hasegawa K, Wakino S, Yoshioka K, Tatematsu S, Hara Y, Minakuchi H, Washida N, Tokuyama H, Hayashi K, Itoh H. Sirt1\u00a0protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun. 2008;372:51\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"1041_CR27","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1016\/j.cellsig.2013.06.007","volume":"25","author":"A Kauppinen","year":"2013","unstructured":"Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-\u03baB and\u00a0SIRT1\u00a0in the regulation of inflammation and metabolic disorders. Cell Signal. 2013;25:1939\u201348.","journal-title":"Cell Signal"},{"key":"1041_CR28","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.metabol.2018.03.004","volume":"83","author":"X Chen","year":"2018","unstructured":"Chen X, Li X, Zhang W, He J, Xu B, Lei B, Wang Z, Cates C, Rousselle T, Li J. Activation of\u00a0AMPK\u00a0inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated\u00a0NF-\u03baB pathway. Metabolism. 2018;83:256\u201370.","journal-title":"Metabolism."},{"key":"1041_CR29","doi-asserted-by":"publisher","first-page":"E1788","DOI":"10.1073\/pnas.1305961110","volume":"110","author":"G Yuan","year":"2013","unstructured":"Yuan G, Peng YJ, Reddy VD, Makarenko VV, Nanduri J, Khan SA, Garcia JA, Kumar GK, Semenza GL, Prabhakar NR. Mutual antagonism between hypoxia-inducible factors 1\u03b1 and 2\u03b1 regulates oxygen sensing and cardio-respiratory homeostasis. Proc Natl Acad Sci USA. 2013;110:E1788\u201396.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1041_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.1881410","volume":"24","author":"N Takeda","year":"2010","unstructured":"Takeda N, O\u2019Dea EL, Doedens A, Kim JW, Weidemann A, Stockmann C, Asagiri M, Simon MC, Hoffmann A, Johnson RS. Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev. 2010;24:491\u2013501.","journal-title":"Genes Dev"},{"key":"1041_CR31","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.2337\/db13-1965","volume":"63","author":"SS Choe","year":"2014","unstructured":"Choe SS, Shin KC, Ka S, Lee YK, Chun JS, Kim JB. Macrophage HIF-2\u03b1 ameliorates\u00a0adipose\u00a0tissue\u00a0inflammation\u00a0and insulin resistance in obesity. Diabetes. 2014;63:3359\u201371.","journal-title":"Diabetes"},{"key":"1041_CR32","first-page":"2774","volume":"19","author":"T Li","year":"2019","unstructured":"Li T, Chen L, Yu Y, Yang B, Li P, Tan XQ. Resveratrol alleviates hypoxia\/reoxygenation injury\u2013induced mitochondrial\u00a0oxidative stress\u00a0in cardiomyocytes. Mol Med Rep. 2019;19:2774\u201380.","journal-title":"Mol Med Rep."},{"key":"1041_CR33","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jnutbio.2015.06.006","volume":"26","author":"PK Bagul","year":"2015","unstructured":"Bagul PK, Deepthi N, Sultana R, Banerjee SK. Resveratrol ameliorates cardiac\u00a0oxidative stress\u00a0in\u00a0diabetes\u00a0through deacetylation of NFkB-p65 and histone 3. J Nutr Biochem. 2015;26:1298\u2013307.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"1041_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12933-018-0754-4","volume":"17","author":"M Waldman","year":"2018","unstructured":"Waldman M, Cohen K, Yadin D, Nudelman V, Gorfil D, Laniado-Schwartzman M, Kornwoski R, Aravot D, Abraham NG, Arad M, Hochhauser E. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving \u2018SIRT1\u00a0and PGC-1\u03b1\u2019. Cardiovasc Diabetol. 2018;17(1):111. https:\/\/doi.org\/10.1186\/s12933-018-0754-4.","journal-title":"Cardiovasc Diabetol."},{"issue":"20","key":"1041_CR35","doi-asserted-by":"publisher","first-page":"E5005","DOI":"10.3390\/ijms20205005","volume":"20","author":"MN Sanz","year":"2019","unstructured":"Sanz MN, Grimbert L, Moulin M, Gressette M, Rucker-Martin C, Lemaire C, Mericskay M, Veksler V, Ventura-Clapier R, Garnier A, Piquereau J. Inducible cardiac-specific deletion of\u00a0Sirt1\u00a0in male mice reveals progressive cardiac dysfunction and sensitization of the\u00a0heart\u00a0to pressure overload. Int J Mol Sci. 2019;20(20):E5005. https:\/\/doi.org\/10.3390\/ijms20205005.","journal-title":"Int J Mol Sci"},{"key":"1041_CR36","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1073\/pnas.0811018106","volume":"106","author":"J Nanduri","year":"2009","unstructured":"Nanduri J, Wang N, Yuan G, Khan SA, Souvannakitti D, Peng YJ, Kumar GK, Garcia JA, Prabhakar NR. Intermittent hypoxia degrades\u00a0HIF-2alpha\u00a0via calpains resulting in\u00a0oxidative stress: implications for recurrent apnea-induced morbidities. Proc Natl Acad Sci USA. 2009;106:1199\u2013204.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1041_CR37","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1073\/pnas.1100064108","volume":"108","author":"YJ Peng","year":"2011","unstructured":"Peng YJ, Nanduri J, Khan SA, Yuan G, Wang N, Kinsman B, Vaddi DR, Kumar GK, Garcia JA, Semenza GL, Prabhakar NR. Hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1) heterozygous-null mice exhibit exaggerated carotid body sensitivity to hypoxia, breathing instability, and hypertension. Proc Natl Acad Sci USA. 2011;108:3065\u201370.","journal-title":"Proc Natl Acad Sci USA."},{"key":"1041_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/cbf.995","volume":"21","author":"O Yildirim","year":"2003","unstructured":"Yildirim O, B\u00fcy\u00fckbing\u00f6l Z. Effect of\u00a0cobalt\u00a0on the oxidative status in\u00a0heart\u00a0and aorta of streptozotocin-induced diabetic rats. Cell Biochem Funct. 2003;21:27\u201333.","journal-title":"Cell Biochem Funct"},{"issue":"5","key":"1041_CR39","doi-asserted-by":"publisher","first-page":"e1185","DOI":"10.1038\/cddis.2014.155","volume":"17","author":"S Gallo","year":"2014","unstructured":"Gallo S, Gatti S, Sala V, Albano R, Costelli P, Casanova E, Comoglio PM, Crepaldi T. Agonist antibodies activating the Met receptor protect cardiomyoblasts from\u00a0cobalt chloride-induced apoptosis and\u00a0autophagy. Cell Death Dis. 2014;17(5):e1185. https:\/\/doi.org\/10.1038\/cddis.2014.155.","journal-title":"Cell Death Dis."},{"key":"1041_CR40","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1242\/jeb.003178","volume":"210","author":"C Gaitanaki","year":"2007","unstructured":"Gaitanaki C, Kalpachidou T, Aggeli IK, Papazafiri P, Beis I. CoCl2 induces protective events via the p38-MAPK signalling pathway and ANP in the perfused amphibian\u00a0heart. J Exp Biol. 2007;210:2267\u201377.","journal-title":"J Exp Biol"},{"key":"1041_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1089\/ars.2009.3014","volume":"13","author":"I Diebold","year":"2010","unstructured":"Diebold I, Fl\u00fcgel D, Becht S, Belaiba RS, Bonello S, Hess J, Kietzmann T, G\u00f6rlach A. The hypoxia-inducible factor-2alpha is stabilized by\u00a0oxidative stress\u00a0involving NOX4. Antioxid Redox Signal. 2010;13:425\u201336.","journal-title":"Antioxid Redox Signal"},{"key":"1041_CR42","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/01.RES.0000188210.72062.10","volume":"97","author":"H Liu","year":"2005","unstructured":"Liu H, Colavitti R, Rovira II, Finkel T. Redox-dependent transcriptional regulation. Circ Res. 2005;97:967\u201374.","journal-title":"Circ Res"},{"key":"1041_CR43","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and\u00a0diabetic complications. Circ Res. 2010;107:1058\u201370.","journal-title":"Circ Res"},{"key":"1041_CR44","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.biocel.2012.09.017","volume":"45","author":"AP Lakshmanan","year":"2013","unstructured":"Lakshmanan AP, Harima M, Suzuki K, Soetikno V, Nagata M, Nakamura T, Takahashi T, Sone H, Kawachi H, Watanabe K. The hyperglycemia stimulated myocardial\u00a0endoplasmic\u00a0reticulum (ER)\u00a0stress\u00a0contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of\u00a0unfolded\u00a0protein response (UPR) signaling\u00a0proteins. Int J Biochem Cell Biol. 2013;45:438\u201347.","journal-title":"Int J Biochem Cell Biol"},{"key":"1041_CR45","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCRESAHA.110.225698","volume":"107","author":"S Hummasti","year":"2010","unstructured":"Hummasti S, Hotamisligil GS. Endoplasmic\u00a0reticulum\u00a0stress\u00a0and inflammation in obesity and\u00a0diabetes. Circ Res. 2010;107:579\u201391.","journal-title":"Circ Res"},{"key":"1041_CR46","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s13679-014-0095-x","volume":"3","author":"XJ Xu","year":"2014","unstructured":"Xu XJ, Valentine RJ, Ruderman NB. AMP-activated\u00a0protein\u00a0kinase (AMPK): does this master regulator of cellular energy state distinguish insulin sensitive from insulin resistant obesity? Curr Obes Rep. 2014;3:248\u201355.","journal-title":"Curr Obes Rep."},{"key":"1041_CR47","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/ijo.2016.131","volume":"40","author":"A Kurylowicz","year":"2016","unstructured":"Kurylowicz A, Owczarz M, Polosak J, Jonas MI, Lisik W, Jonas M, Chmura A, Puzianowska-Kuznicka M. SIRT1\u00a0and SIRT7\u00a0expression\u00a0in adipose tissues of\u00a0obese\u00a0and normal-weight individuals is regulated by microRNAs but not by methylation status. Int J Obes. 2016;40:1635\u201342.","journal-title":"Int J Obes"},{"key":"1041_CR48","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1080\/15548627.2017.1358848","volume":"13","author":"Y Wang","year":"2017","unstructured":"Wang Y, Liang B, Lau WB, Du Y, Guo R, Yan Z, Gan L, Yan W, Zhao J, Gao E, Koch W, Ma XL. Restoring\u00a0diabetes-induced autophagic flux arrest in ischemic\/reperfused\u00a0heart\u00a0by ADIPOR (adiponectin receptor) activation involves both\u00a0AMPK-dependent and\u00a0AMPK-independent signaling. Autophagy. 2017;13:1855\u201369.","journal-title":"Autophagy."},{"key":"1041_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/1440-1681.12194","volume":"41","author":"Q Yuan","year":"2014","unstructured":"Yuan Q, Zhou QY, Liu D, Yu L, Zhan L, Li XJ, Peng HY, Zhang XL, Yuan XC. Advanced glycation end-products impair Na+\/K+-ATPase activity in diabetic cardiomyopathy: role of the adenosine monophosphate-activated\u00a0protein\u00a0kinase\/sirtuin 1 pathway. Clin Exp Pharmacol Physiol. 2014;41:127\u201333.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1041_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.biocel.2018.10.011","volume":"105","author":"A Tao","year":"2018","unstructured":"Tao A, Xu X, Kvietys P, Kao R, Martin C, Rui T. Experimental\u00a0diabetes mellitus\u00a0exacerbates ischemia\/reperfusion-induced myocardial injury by promoting mitochondrial fission: role of down-regulation of myocardial\u00a0Sirt1\u00a0and subsequent Akt\/Drp1 interaction. Int J Biochem Cell Biol. 2018;105:94\u2013103.","journal-title":"Int J Biochem Cell Biol"},{"key":"1041_CR51","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.biopha.2017.03.056","volume":"90","author":"H Karbasforooshan","year":"2017","unstructured":"Karbasforooshan H, Karimi G. The role of\u00a0SIRT1\u00a0in diabetic cardiomyopathy. Biomed Pharmacother. 2017;90:386\u201392.","journal-title":"Biomed Pharmacother"},{"key":"1041_CR52","doi-asserted-by":"publisher","first-page":"4602715","DOI":"10.1155\/2017\/4602715","volume":"2017","author":"S Ma","year":"2017","unstructured":"Ma S, Feng J, Zhang R, Chen J, Han D, Li X, Yang B, Li X, Fan M, Li C, Tian Z, Wang Y, Cao F. SIRT1\u00a0activation by\u00a0resveratrol\u00a0alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy mice. Oxid Med Cell Longev. 2017;2017:4602715. https:\/\/doi.org\/10.1155\/2017\/4602715.","journal-title":"Oxid Med Cell Longev."},{"key":"1041_CR53","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijcard.2015.04.245","volume":"191","author":"R Guo","year":"2015","unstructured":"Guo R, Liu W, Liu B, Zhang B, Li W, Xu Y. SIRT1\u00a0suppresses cardiomyocyte apoptosis in diabetic cardiomyopathy: an insight into endoplasmic reticulum stress response mechanism. Int J Cardiol. 2015;191:36\u201345.","journal-title":"Int J Cardiol"},{"key":"1041_CR54","doi-asserted-by":"publisher","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","volume":"298","author":"M Sulaiman","year":"2010","unstructured":"Sulaiman M, Matta MJ, Sunderesan NR, Gupta MP, Periasamy M, Gupta M. Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2010;298:H833\u201343.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"1041_CR55","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1111\/jcmm.12556","volume":"19","author":"H Zeng","year":"2015","unstructured":"Zeng H, Vaka VR, He X, Booz GW, Chen JX. High-fat diet induces cardiac remodelling and dysfunction: assessment of the role played by SIRT3 loss. J Cell Mol Med. 2015;19:1847\u201356.","journal-title":"J Cell Mol Med"},{"key":"1041_CR56","doi-asserted-by":"publisher","first-page":"3480637","DOI":"10.1155\/2016\/3480637","volume":"2016","author":"R Mastrocola","year":"2016","unstructured":"Mastrocola R, Collino M, Penna C, Nigro D, Chiazza F, Fracasso V, Tullio F, Alloatti G, Pagliaro P, Aragno M. Maladaptive modulations of NLRP3 inflammasome and cardioprotective pathways are involved in diet-induced exacerbation of myocardial ischemia\/reperfusion injury in mice. Oxid Med Cell Longev. 2016;2016:3480637. https:\/\/doi.org\/10.1155\/2016\/3480637.","journal-title":"Oxid Med Cell Longev."},{"key":"1041_CR57","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.bbrc.2006.11.027","volume":"352","author":"M Heidbreder","year":"2007","unstructured":"Heidbreder M, Qadri F, J\u00f6hren O, Dendorfer A, Depping R, Fr\u00f6hlich F, Wagner KF, Dominiak P. Non-hypoxic induction of HIF-3alpha by 2-deoxy-d-glucose and insulin. Biochem Biophys Res Commun. 2007;352:437\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1041_CR58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1743-7075-3-31","volume":"10","author":"S Giri","year":"2006","unstructured":"Giri S, Rattan R, Haq E, Khan M, Yasmin R, Won JS, Key L, Singh AK, Singh I. AICAR\u00a0inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutr Metab. 2006;10(3):31.","journal-title":"Nutr Metab"},{"key":"1041_CR59","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.bmcl.2018.01.021","volume":"28","author":"MJ Kim","year":"2018","unstructured":"Kim MJ, An HJ, Kim DH, Lee B, Lee HJ, Ullah S, Kim SJ, Jeong HO, Moon KM, Lee EK, Yang J, Akter J, Chun P, Moon HR, Chung HY. Novel\u00a0SIRT1\u00a0activator MHY2233 improves\u00a0glucose\u00a0tolerance\u00a0and reduces hepatic lipid accumulation in db\/db mice. Bioorg Med Chem Lett. 2018;28:684\u20138.","journal-title":"Bioorg Med Chem Lett"},{"issue":"7","key":"1041_CR60","doi-asserted-by":"publisher","first-page":"E1180","DOI":"10.3390\/molecules22071180","volume":"22","author":"CY Yonamine","year":"2017","unstructured":"Yonamine CY, Pinheiro-Machado E, Michalani ML, Alves-Wagner AB, Esteves JV, Freitas HS, Machado UF. Resveratrol improves glycemic control in type 2 diabetic obese mice by regulating\u00a0glucose\u00a0transporter expression in skeletal muscle and liver. Molecules. 2017;22(7):E1180. https:\/\/doi.org\/10.3390\/molecules22071180.","journal-title":"Molecules"},{"key":"1041_CR61","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.2337\/db17-0186","volume":"66","author":"A Thomas","year":"2017","unstructured":"Thomas A, Belaidi E, Moulin S, Horman S, van der Zon GC, Viollet B, Levy P, Bertrand L, Pepin JL, Godin-Ribuot D, Guigas B. Chronic intermittent hypoxia impairs insulin sensitivity but improves whole-body\u00a0glucose\u00a0tolerance\u00a0by activating skeletal muscle\u00a0AMPK. Diabetes. 2017;66:2942\u201351.","journal-title":"Diabetes"},{"key":"1041_CR62","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1177\/1535370217723578","volume":"242","author":"TV Serebrovska","year":"2017","unstructured":"Serebrovska TV, Portnychenko AG, Drevytska TI, Portnichenko VI, Xi L, Egorov E, Gavalko AV, Naskalova S, Chizhova V, Shatylo VB. Intermittent\u00a0hypoxia\u00a0training in prediabetes patients: beneficial effects on\u00a0glucose\u00a0homeostasis,\u00a0hypoxia\u00a0tolerance and gene expression. Exp Biol Med. 2017;242:1542\u201352.","journal-title":"Exp Biol Med"},{"key":"1041_CR63","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/nm.3295","volume":"19","author":"K Wei","year":"2013","unstructured":"Wei K, Piecewicz SM, McGinnis LM, Taniguchi CM, Wiegand SJ, Anderson K, Chan CW, Mulligan KX, Kuo D, Yuan J, Vallon M, Morton L, Lefai E, Simon MC, Maher JJ, Mithieux G, Rajas F, Annes J, McGuinness OP, Thurston G, Giaccia AJ, Kuo CJ. A liver Hif-2\u03b1-Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition. Nat Med. 2013;19:1331\u20137.","journal-title":"Nat Med"},{"key":"1041_CR64","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/NHA-170022","volume":"4","author":"SK Ramakrishnan","year":"2017","unstructured":"Ramakrishnan SK, Shah YM. A central role for hypoxia-inducible factor (HIF)-2\u03b1 in hepatic glucose homeostasis. Nutr Healthy Aging. 2017;4:207\u201316.","journal-title":"Nutr Healthy Aging."},{"key":"1041_CR65","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/nm.3294","volume":"19","author":"CM Taniguchi","year":"2013","unstructured":"Taniguchi CM, Finger EC, Krieg AJ, Wu C, Diep AN, LaGory EL, Wei K, McGinnis LM, Yuan J, Kuo CJ, Giaccia AJ. Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic\u00a0glucose\u00a0and lipid metabolism and ameliorates diabetes. Nat Med. 2013;19:1325\u201330.","journal-title":"Nat Med"},{"key":"1041_CR66","doi-asserted-by":"publisher","first-page":"39192","DOI":"10.1074\/jbc.C100428200","volume":"276","author":"K Brusselmans","year":"2001","unstructured":"Brusselmans K, Bono F, Maxwell P, Dor Y, Dewerchin M, Collen D, Herbert JM, Carmeliet P. Hypoxia-inducible factor-2alpha (HIF-2alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia. J Biol Chem. 2001;276:39192\u20136.","journal-title":"J Biol Chem"},{"key":"1041_CR67","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nature10758","volume":"481","author":"C He","year":"2012","unstructured":"He C, Bassik MC, Moresi V, Sun K, Wei Y, Zou Z, An Z, Loh J, Fisher J, Sun Q, Korsmeyer S, Packer M, May HI, Hill JA, Virgin HW, Gilpin C, Xiao G, Bassel-Duby R, Scherer PE, Levine B. Exercise-induced BCL2-regulated\u00a0autophagy\u00a0is required for muscle\u00a0glucose\u00a0homeostasis. Nature. 2012;481:511\u20135.","journal-title":"Nature"},{"key":"1041_CR68","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.mce.2017.03.029","volume":"448","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Ling Y, Yang L, Cheng Y, Yang P, Song X, Tang H, Zhong Y, Tang L, He S, Yang S, Chen A, Wang X. Liraglutide relieves myocardial damage by promoting\u00a0autophagy\u00a0via AMPK-mTOR signaling pathway in Zucker diabetic fatty rat. Mol Cell Endocrinol. 2017;448:98\u2013107.","journal-title":"Mol Cell Endocrinol"},{"key":"1041_CR69","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10557-018-6831-9","volume":"32","author":"Y Zhou","year":"2018","unstructured":"Zhou Y, Wang H, Man F, Guo Z, Xu J, Yan W, Li J, Pan Q, Wang W. Sitagliptin protects cardiac function by reducing nitroxidative stress and promoting\u00a0autophagy\u00a0in Zucker diabetic fatty (ZDF) rats. Cardiovasc Drugs Ther. 2018;32:541\u201352.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1041_CR70","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1097\/HJH.0b013e328302f0f7","volume":"26","author":"MF Kato","year":"2008","unstructured":"Kato MF, Shibata R, Obata K, Miyachi M, Yazawa H, Tsuboi K, Yamada T, Nishizawa T, Noda A, Cheng XW, Murate T, Koike Y, Murohara T, Yokota M, Nagata K. Pioglitazone\u00a0attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of\u00a0AMP-activat-ed\u00a0protein\u00a0kinase and inhibition of Akt. J Hypertens. 2008;26:1669\u201376.","journal-title":"J Hypertens"},{"key":"1041_CR71","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1055\/s-0033-1347209","volume":"45","author":"S Paula-Gomes","year":"2013","unstructured":"Paula-Gomes S, Gon\u00e7alves DA, Baviera AM, Zanon NM, Navegantes LC, Kettelhut IC. Insulin\u00a0suppresses atrophy- and\u00a0autophagy-related genes in heart tissue and cardiomyocytes through AKT\/FOXO signaling. Horm Metab Res. 2013;45:849\u201355.","journal-title":"Horm Metab Res"},{"key":"1041_CR72","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jacbts.2018.04.003","volume":"3","author":"M Packer","year":"2018","unstructured":"Packer M. Potentiation of\u00a0insulin\u00a0signaling contributes to heart failure in\u00a0type\u00a02\u00a0diabetes: a hypothesis supported by both mechanistic studies and\u00a0clinical trials. JACC Basic Transl Sci. 2018;3:415\u20139.","journal-title":"JACC Basic Transl Sci."},{"issue":"1","key":"1041_CR73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12933-017-0648-x","volume":"17","author":"M Packer","year":"2018","unstructured":"Packer M. Have dipeptidyl peptidase-4 inhibitors ameliorated the vascular complications of type 2 diabetes in large-scale trials? The potential confounding effect of stem-cell\u00a0chemokines. Cardiovasc Diabetol. 2018;17(1):9. https:\/\/doi.org\/10.1186\/s12933-017-0648-x.","journal-title":"Cardiovasc Diabetol."},{"issue":"11","key":"1041_CR74","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fnins.2017.00078","volume":"16","author":"PM Coly","year":"2017","unstructured":"Coly PM, Gandolfo P, Castel H, Morin F. The\u00a0autophagy\u00a0machinery: a new player in chemotactic cell migration. Front Neurosci. 2017;16(11):78. https:\/\/doi.org\/10.3389\/fnins.2017.00078.","journal-title":"Front Neurosci."},{"key":"1041_CR75","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.2337\/db10-0351","volume":"60","author":"Z Xie","year":"2011","unstructured":"Xie Z, Lau K, Eby B, Lozano P, He C, Pennington B, Li H, Rathi S, Dong Y, Tian R, Kem D, Zou MH. Improvement of cardiac functions by chronic\u00a0metformin\u00a0treatment is associated with enhanced cardiac\u00a0autophagy\u00a0in diabetic OVE26 mice. Diabetes. 2011;60:1770\u20138.","journal-title":"Diabetes"},{"key":"1041_CR76","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.lfs.2019.04.002","volume":"225","author":"Y Wang","year":"2019","unstructured":"Wang Y, Yang Z, Zheng G, Yu L, Yin Y, Mu N, Ma H. Metformin\u00a0promotes\u00a0autophagy\u00a0in ischemia\/reperfusion myocardium via cytoplasmic AMPK\u03b11 and nuclear AMPK\u03b12 pathways. Life Sci. 2019;225:64\u201371.","journal-title":"Life Sci"},{"key":"1041_CR77","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/CIRCULATIONAHA.108.798561","volume":"119","author":"H Sasaki","year":"2009","unstructured":"Sasaki H, Asanuma H, Fujita M, Takahama H, Wakeno M, Ito S, Ogai A, Asakura M, Kim J, Minamino T, Takashima S, Sanada S, Sugimachi M, Komamura K, Mochizuki N, Kitakaze M. Metformin\u00a0prevents progression of\u00a0heart\u00a0failure in dogs: role of AMP-activated protein kinase. Circulation. 2009;119:2568\u201377.","journal-title":"Circulation"},{"issue":"5","key":"1041_CR78","doi-asserted-by":"publisher","first-page":"E1184","DOI":"10.3390\/molecules23051184","volume":"23","author":"R Zilinyi","year":"2018","unstructured":"Zilinyi R, Czompa A, Czegledi A, Gajtko A, Pituk D, Lekli I, Tosaki A. The cardioprotective effect of\u00a0metformin\u00a0in doxorubicin-induced cardiotoxicity: the role of\u00a0autophagy. Molecules. 2018;23(5):E1184. https:\/\/doi.org\/10.3390\/molecules23051184.","journal-title":"Molecules"},{"key":"1041_CR79","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of\u00a0AMP-activated\u00a0protein\u00a0kinase in mechanism of\u00a0metformin\u00a0action. J Clin Invest. 2001;108:1167\u201374.","journal-title":"J Clin Invest."},{"issue":"8","key":"1041_CR80","doi-asserted-by":"publisher","first-page":"e0182777","DOI":"10.1371\/journal.pone.0182777","volume":"12","author":"X Wang","year":"2017","unstructured":"Wang X, Yang L, Kang L, Li J, Yang L, Zhang J, Liu J, Zhu M, Zhang Q, Shen Y, Qi Z. Metformin\u00a0attenuates myocardial ischemia-reperfusion injury via up-regulation of\u00a0antioxidant\u00a0enzymes. PLoS ONE. 2017;12(8):e0182777. https:\/\/doi.org\/10.1371\/journal.pone.0182777.","journal-title":"PLoS ONE"},{"key":"1041_CR81","doi-asserted-by":"publisher","first-page":"H749","DOI":"10.1152\/ajpheart.00414.2014","volume":"308","author":"G Barreto-Torres","year":"2015","unstructured":"Barreto-Torres G, Hernandez JS, Jang S, Rodr\u00edguez-Mu\u00f1oz AR, Torres-Ramos CA, Basnakian AG, Javadov S. The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPAR\u03b1-cyclophilin D interaction in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2015;308:H749\u201358.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"1041_CR82","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1016\/j.freeradbiomed.2011.08.015","volume":"51","author":"MC Asensio-L\u00f3pez","year":"2011","unstructured":"Asensio-L\u00f3pez MC, Lax A, Pascual-Figal DA, Vald\u00e9s M, S\u00e1nchez-M\u00e1s J. Metformin\u00a0protects against doxorubicin-induced cardiotoxicity: involvement of the adiponectin\u00a0cardiac\u00a0system. Free Radic Biol Med. 2011;51:1861\u201371.","journal-title":"Free Radic Biol Med."},{"key":"1041_CR83","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","volume":"91","author":"EP Daskalopoulos","year":"2016","unstructured":"Daskalopoulos EP, Dufeys C, Bertrand L, Beauloye C, Horman S. AMPK in\u00a0cardiac\u00a0fibrosis and repair: actions beyond metabolic regulation. J Mol Cell Cardiol. 2016;91:188\u2013200.","journal-title":"J Mol Cell Cardiol"},{"key":"1041_CR84","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.113.02619","volume":"63","author":"X Xu","year":"2014","unstructured":"Xu X, Lu Z, Fassett J, Zhang P, Hu X, Liu X, Kwak D, Li J, Zhu G, Tao Y, Hou M, Wang H, Guo H, Viollet B, McFalls EO, Bache RJ, Chen Y. Metformin\u00a0protects against systolic overload-induced\u00a0heart\u00a0failure independent of\u00a0AMP-activated\u00a0protein\u00a0kinase \u03b12. Hypertension. 2014;63:723\u20138.","journal-title":"Hypertension"},{"key":"1041_CR85","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mce.2016.11.011","volume":"440","author":"SC Chen","year":"2017","unstructured":"Chen SC, Brooks R, Houskeeper J, Bremner SK, Dunlop J, Viollet B, Logan PJ, Salt IP, Ahmed SF, Yarwood SJ. Metformin\u00a0suppresses adipogenesis through both\u00a0AMP-activated\u00a0protein\u00a0kinase (AMPK)-dependent and\u00a0AMPK-independent mechanisms. Mol Cell Endocrinol. 2017;440:57\u201368.","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"1041_CR86","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fendo.2018.00657","volume":"6","author":"E Cuy\u00e0s","year":"2018","unstructured":"Cuy\u00e0s E, Verdura S, Llorach-Par\u00e9s L, Fern\u00e1ndez-Arroyo S, Joven J, Martin-Castillo B, Bosch-Barrera J, Brunet J, Nonell-Canals A, Sanchez-Martinez M, Menendez JA. Metformin\u00a0Is a direct\u00a0SIRT1-activating compound: computational modeling and experimental validation. Front Endocrinol. 2018;6(9):657. https:\/\/doi.org\/10.3389\/fendo.2018.00657.","journal-title":"Front Endocrinol"},{"key":"1041_CR87","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41591-018-0125-4","volume":"24","author":"AK Madiraju","year":"2018","unstructured":"Madiraju AK, Qiu Y, Perry RJ, Rahimi Y, Zhang XM, Zhang D, Camporez JG, Cline GW, Butrico GM, Kemp BE, Casals G, Steinberg GR, Vatner DF, Petersen KF, Shulman GI. Metformin\u00a0inhibits\u00a0gluconeogenesis\u00a0via a redox-dependent mechanism in vivo. Nat Med. 2018;24:1384\u201394.","journal-title":"Nat Med"},{"key":"1041_CR88","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2337\/dc11-1299","volume":"35","author":"Diabetes Prevention Program Research Group","year":"2012","unstructured":"Diabetes Prevention Program Research Group. Long-term safety, tolerability, and weight loss associated with\u00a0metformin\u00a0in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2012;35:731\u20137.","journal-title":"Diabetes Care"},{"key":"1041_CR89","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.12659\/MSM.906687","volume":"24","author":"Q Yang","year":"2018","unstructured":"Yang Q, Guo X, Yang L. Metformin\u00a0enhances the effect of regorafenib and inhibits recurrence and metastasis of hepatic carcinoma after liver resection via regulating expression of hypoxia inducible factors 2\u03b1 (HIF-2\u03b1) and 30\u00a0kDa HIV Tat-Interacting protein (TIP30). Med Sci Monit. 2018;24:2225\u201334.","journal-title":"Med Sci Monit"},{"issue":"5","key":"1041_CR90","doi-asserted-by":"publisher","first-page":"123130","DOI":"10.1172\/jci.insight.123130","volume":"4","author":"S Osataphan","year":"2019","unstructured":"Osataphan S, Macchi C, Singhal G, Chimene-Weiss J, Sales V, Kozuka C, Dreyfuss JM, Pan H, Tangcharoenpaisan Y, Morningstar J, Gerszten R, Patti ME. SGLT2\u00a0inhibition reprograms systemic metabolism via FGF21-dependent and -independent mechanisms. JCI Insight. 2019;4(5):123130. https:\/\/doi.org\/10.1172\/jci.insight.123130.","journal-title":"JCI Insight."},{"key":"1041_CR91","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1042\/CS20190863","volume":"133","author":"MT Swe","year":"2019","unstructured":"Swe MT, Thongnak L, Jaikumkao K, Pongchaidecha A, Chatsudthipong V, Lungkaphin A. Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats. Clin Sci. 2019;133:2415\u201330.","journal-title":"Clin Sci"},{"key":"1041_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28141","author":"JW Kim","year":"2018","unstructured":"Kim JW, Lee YJ, You YH, Moon MK, Yoon KH, Ahn YB, Ko SH. Effect of sodium-glucose cotransporter 2 inhibitor,\u00a0empagliflozin, and \u03b1-glucosidase inhibitor, voglibose, on hepatic steatosis in an animal model of type 2 diabetes. J Cell Biochem. 2018. https:\/\/doi.org\/10.1002\/jcb.28141(Epub ahead of print).","journal-title":"J Cell Biochem"},{"key":"1041_CR93","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.18632\/aging.101954","volume":"11","author":"Y Ying","year":"2019","unstructured":"Ying Y, Jiang C, Zhang M, Jin J, Ge S, Wang X. Phloretin protects against\u00a0cardiac\u00a0damage and remodeling via restoring\u00a0SIRT1\u00a0and anti-inflammatory effects in the streptozotocin-induced diabetic mouse model. Aging. 2019;11:2822\u201335.","journal-title":"Aging"},{"key":"1041_CR94","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-03686-x","author":"HE Mohamed","year":"2020","unstructured":"Mohamed HE, Asker ME, Keshawy MM, Hasan RA, Mahmoud YK. Inhibition of tumor necrosis factor-\u03b1 enhanced the antifibrotic effect of\u00a0empagliflozin\u00a0in an animal model with renal insulin resistance. Mol Cell Biochem. 2020. https:\/\/doi.org\/10.1007\/s11010-020-03686-x(Epub ahead of print).","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"1041_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12933-019-0964-4","volume":"18","author":"Q Shao","year":"2019","unstructured":"Shao Q, Meng L, Lee S, Tse G, Gong M, Zhang Z, Zhao J, Zhao Y, Li G, Liu T. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates\u00a0atrial\u00a0remodeling and improves mitochondrial function in high-fat diet\/streptozotocin-induced diabetic rats. Cardiovasc Diabetol. 2019;18(1):165. https:\/\/doi.org\/10.1186\/s12933-019-0964-4.","journal-title":"Cardiovasc Diabetol."},{"key":"1041_CR96","doi-asserted-by":"publisher","first-page":"117414","DOI":"10.1016\/j.lfs.2020.117414","volume":"247","author":"D Wei","year":"2020","unstructured":"Wei D, Liao L, Wang H, Zhang W, Wang T, Xu Z. Canagliflozin ameliorates obesity by improving mitochondrial function and fatty acid oxidation via PPAR\u03b1 in vivo and in vitro. Life Sci. 2020;247:117414. https:\/\/doi.org\/10.1016\/j.lfs.2020.117414(Epub ahead of print).","journal-title":"Life Sci"},{"issue":"1","key":"1041_CR97","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1038\/s41598-018-23420-4","volume":"8","author":"SJ Mancini","year":"2018","unstructured":"Mancini SJ, Boyd D, Katwan OJ, Strembitska A, Almabrouk TA, Kennedy S, Palmer TM, Salt IP. Canagliflozin inhibits interleukin-1\u03b2-stimulated cytokine and chemokine secretion in vascular endothelial cells by\u00a0AMP-activated\u00a0protein\u00a0kinase-dependent and -independent mechanisms. Sci Rep. 2018;8(1):5276. https:\/\/doi.org\/10.1038\/s41598-018-23420-4.","journal-title":"Sci Rep."},{"key":"1041_CR98","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/db16-0058","volume":"65","author":"SA Hawley","year":"2016","unstructured":"Hawley SA, Ford RJ, Smith BK, Gowans GJ, Mancini SJ, Pitt RD, Day EA, Salt IP, Steinberg GR, Hardie DG. The Na+\/glucose cotransporter inhibitor canagliflozin activates\u00a0AMPK\u00a0by inhibiting mitochondrial function and increasing cellular AMP levels. Diabetes. 2016;65:2784\u201394.","journal-title":"Diabetes"},{"issue":"1","key":"1041_CR99","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12967-019-1881-8","volume":"17","author":"AA Sayour","year":"2019","unstructured":"Sayour AA, Korkmaz-Ic\u00f6z S, Loganathan S, Ruppert M, Sayour VN, Ol\u00e1h A, Benke K, Brune M, Benk\u0151 R, Horv\u00e1th EM, Karck M, Merkely B, Radovits T, Szab\u00f3 G. Acute canagliflozin treatment protects against in vivo myocardial ischemia-reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation. J Transl Med. 2019;17(1):127. https:\/\/doi.org\/10.1186\/s12967-019-1881-8.","journal-title":"J Transl Med."},{"key":"1041_CR100","doi-asserted-by":"publisher","first-page":"113677","DOI":"10.1016\/j.bcp.2019.113677","volume":"170","author":"A Arag\u00f3n-Herrera","year":"2019","unstructured":"Arag\u00f3n-Herrera A, Feij\u00f3o-Band\u00edn S, Otero Santiago M, Barral L, Campos-Toimil M, Gil-Longo J, Costa Pereira TM, Garc\u00eda-Caballero T, Rodr\u00edguez-Segade S, Rodr\u00edguez J, Taraz\u00f3n E, Rosell\u00f3-Llet\u00ed E, Portol\u00e9s M, Gualillo O, Gonz\u00e1lez-Juanatey JR, Lago F. Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving\u00a0autophagy\u00a0in the hearts of Zucker diabetic fatty rats. Biochem Pharmacol. 2019;170:113677. https:\/\/doi.org\/10.1016\/j.bcp.2019.113677.","journal-title":"Biochem Pharmacol"},{"key":"1041_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2019.110642","author":"Q Lu","year":"2019","unstructured":"Lu Q, Liu J, Li X, Sun X, Zhang J, Ren D, Tong N, Li J. Empagliflozin\u00a0attenuates ischemia and reperfusion injury through LKB1\/AMPK\u00a0signaling pathway. Mol Cell Endocrinol. 2019. https:\/\/doi.org\/10.1016\/j.mce.2019.110642(Epub ahead of print).","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"1041_CR102","doi-asserted-by":"publisher","first-page":"e0158810","DOI":"10.1371\/journal.pone.0158810","volume":"11","author":"YK Chang","year":"2016","unstructured":"Chang YK, Choi H, Jeong JY, Na KR, Lee KW, Lim BJ, Choi DE. Dapagliflozin,\u00a0SGLT2\u00a0inhibitor, attenuates renal ischemia-reperfusion injury. PLoS ONE. 2016;11(7):e0158810. https:\/\/doi.org\/10.1371\/journal.pone.0158810.","journal-title":"PLoS ONE"},{"key":"1041_CR103","doi-asserted-by":"publisher","DOI":"10.3390\/cells8091085","author":"WC Lee","year":"2019","unstructured":"Lee WC, Chau YY, Ng HY, Chen CH, Wang PW, Liou CW, Lin TK, Chen JB. Empagliflozin\u00a0protects HK-2 cells from high glucose-mediated injuries via a mitochondrial mechanism. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8091085.","journal-title":"Cells"},{"key":"1041_CR104","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.redox.2017.12.019","volume":"15","author":"H Zhou","year":"2018","unstructured":"Zhou H, Wang S, Zhu P, Hu S, Chen Y, Ren J. Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission. Redox Biol. 2018;15:335\u201346.","journal-title":"Redox Biol."},{"issue":"1","key":"1041_CR105","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41467-017-00520-9","volume":"8","author":"RC Laker","year":"2017","unstructured":"Laker RC, Drake JC, Wilson RJ, Lira VA, Lewellen BM, Ryall KA, Fisher CC, Zhang M, Saucerman JJ, Goodyear LJ, Kundu M, Yan Z. Ampk\u00a0phosphorylation of Ulk1 is required for targeting of\u00a0mitochondria\u00a0to lysosomes in exercise-induced mitophagy. Nat Commun. 2017;8(1):548. https:\/\/doi.org\/10.1038\/s41467-017-00520-9.","journal-title":"Nat Commun."},{"key":"1041_CR106","doi-asserted-by":"publisher","first-page":"C710","DOI":"10.1152\/ajpcell.00380.2014","volume":"308","author":"A Vainshtein","year":"2015","unstructured":"Vainshtein A, Tryon LD, Pauly M, Hood DA. Role of PGC-1\u03b1 during acute exercise-induced\u00a0autophagy\u00a0and mitophagy in skeletal muscle. Am J Physiol Cell Physiol. 2015;308:C710\u20139.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"1041_CR107","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12933-019-0820-6","volume":"18","author":"DD Adingupu","year":"2019","unstructured":"Adingupu DD, G\u00f6pel SO, Gr\u00f6nros J, Behrendt M, Sotak M, Miliotis T, Dahlqvist U, Gan LM, J\u00f6nsson-Rylander AC. SGLT2\u00a0inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob\/ob-\/-\u00a0mice. Cardiovasc Diabetol. 2019;18(1):16. https:\/\/doi.org\/10.1186\/s12933-019-0820-6.","journal-title":"Cardiovasc Diabetol."},{"key":"1041_CR108","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.4070\/kcj.2019.0180","volume":"49","author":"CM Oh","year":"2019","unstructured":"Oh CM, Cho S, Jang JY, Kim H, Chun S, Choi M, Park S, Ko YG. Cardioprotective potential of an\u00a0SGLT2\u00a0inhibitor against doxorubicin-induced heart failure. Korean Circ J. 2019;49:1183\u201395.","journal-title":"Korean Circ J."},{"key":"1041_CR109","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.lfs.2019.05.051","volume":"230","author":"T Takasu","year":"2019","unstructured":"Takasu T, Takakura S. Effect of ipragliflozin, an\u00a0SGLT2\u00a0inhibitor, on cardiac histopathological changes in a non-diabetic rat model of\u00a0cardiomyopathy. Life Sci. 2019;230:19\u201327.","journal-title":"Life Sci"},{"key":"1041_CR110","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00125-005-0091-5","volume":"49","author":"R Anzawa","year":"2006","unstructured":"Anzawa R, Bernard M, Tamareille S, Baetz D, Confort-Gouny S, Gascard JP, Cozzone P, Feuvray D. Intracellular sodium\u00a0increase and susceptibility to ischaemia in hearts from type 2 diabetic db\/db mice. Diabetologia. 2006;49:598\u2013606.","journal-title":"Diabetologia"},{"key":"1041_CR111","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1113\/expphysiol.1991.sp003478","volume":"76","author":"D Lagadic-Gossmann","year":"1991","unstructured":"Lagadic-Gossmann D, Feuvray D. Intracellular sodium\u00a0activity in papillary muscle from diabetic rat hearts. Exp Physiol. 1991;76:147\u20139.","journal-title":"Exp Physiol"},{"key":"1041_CR112","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cvr\/cvx149","volume":"114","author":"E Bertero","year":"2018","unstructured":"Bertero E, Prates Roma L, Ameri P, Maack C. Cardiac effects of SGLT2 inhibitors: the sodium hypothesis. Cardiovasc Res. 2018;114:12\u20138.","journal-title":"Cardiovasc Res"},{"key":"1041_CR113","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/CIRCRESAHA.108.189050","volume":"104","author":"E Murphy","year":"2009","unstructured":"Murphy E, Eisner DA. Regulation of intracellular and mitochondrial sodium in health and disease. Circ Res. 2009;104:292\u2013303.","journal-title":"Circ Res"},{"key":"1041_CR114","doi-asserted-by":"publisher","first-page":"20","DOI":"10.4161\/chan.27423","volume":"8","author":"F Lang","year":"2014","unstructured":"Lang F, F\u00f6ller M. Regulation of ion channels and transporters by\u00a0AMP-activated\u00a0kinase (AMPK). Channels. 2014;8:20\u20138.","journal-title":"Channels"},{"key":"1041_CR115","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00424-006-0124-z","volume":"453","author":"TR Moopanar","year":"2006","unstructured":"Moopanar TR, Xiao XH, Jiang L, Chen ZP, Kemp BE, Allen DG. AICAR inhibits the Na+\/H+\u2009exchanger in rat hearts\u2013possible contribution to cardioprotection. Pflugers Arch. 2006;453:147\u201356.","journal-title":"Pflugers Arch"},{"key":"1041_CR116","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nm.4284","volume":"23","author":"A Vikram","year":"2017","unstructured":"Vikram A, Lewarchik CM, Yoon JY, Naqvi A, Kumar S, Morgan GM, Jacobs JS, Li Q, Kim YR, Kassan M, Liu J, Gabani M, Kumar A, Mehdi H, Zhu X, Guan X, Kutschke W, Zhang X, Boudreau RL, Dai S, Matasic DS, Jung SB, Margulies KB, Kumar V, Bachschmid MM, London B, Irani K. Sirtuin 1\u00a0regulates cardiac electrical activity by deacetylating the cardiac\u00a0sodium channel. Nat Med. 2017;23:361\u20137.","journal-title":"Nat Med"},{"key":"1041_CR117","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s00125-017-4509-7","volume":"61","author":"L Uthman","year":"2018","unstructured":"Uthman L, Baartscheer A, Bleijlevens B, Schumacher CA, Fiolet JWT, Koeman A, Jancev M, Hollmann MW, Weber NC, Coronel R, Zuurbier CJ. Class effects of SGLT2 inhibitors in mouse cardiomyocytes and hearts: inhibition of Na\u2009+\/H\u2009+\u2009exchanger, lowering of cytosolic Na\u2009+\u2009and vasodilation. Diabetologia. 2018;61:722\u20136.","journal-title":"Diabetologia"},{"key":"1041_CR118","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ebiom.2017.05.028","volume":"20","author":"L Xu","year":"2017","unstructured":"Xu L, Nagata N, Nagashimada M, Zhuge F, Ni Y, Chen G, Mayoux E, Kaneko S, Ota T. SGLT2\u00a0inhibition by empagliflozin promotes fat utilization and browning and attenuates inflammation and insulin resistance by polarizing M2 macrophages in diet-induced obese mice. EBioMedicine. 2017;20:137\u201349.","journal-title":"EBioMedicine."},{"issue":"866","key":"1041_CR119","doi-asserted-by":"publisher","first-page":"172810","DOI":"10.1016\/j.ejphar.2019.172810","volume":"5","author":"H Nambu","year":"2020","unstructured":"Nambu H, Takada S, Fukushima A, Matsumoto J, Kakutani N, Maekawa S, Shirakawa R, Nakano I, Furihata T, Katayama T, Yamanashi K, Obata Y, Saito A, Yokota T, Kinugawa S. Empagliflozin restores lowered exercise endurance capacity via the activation of\u00a0skeletal muscle\u00a0fatty acid oxidation in a murine model of heart failure. Eur J Pharmacol. 2020;5(866):172810. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172810.","journal-title":"Eur J Pharmacol"},{"key":"1041_CR120","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","volume":"393","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2019;393:31\u20139.","journal-title":"Lancet"},{"key":"1041_CR121","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, B\u00f6hm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, Duk\u00e1t A, Ge J, Howlett JG, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O\u2019Meara E, Petrie MC, Vinh PN, Schou M, Tereshchenko S, Verma S, Held C, DeMets DL, Docherty KF, Jhund PS, Bengtsson O, Sj\u00f6strand M, Langkilde AM, DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995\u20132008.","journal-title":"N Engl J Med"},{"issue":"21","key":"1041_CR122","doi-asserted-by":"publisher","first-page":"e011640","DOI":"10.1161\/JAHA.118.011640","volume":"8","author":"CH Tseng","year":"2019","unstructured":"Tseng CH. Metformin\u00a0use is associated with a lower risk of\u00a0hospitalization\u00a0for\u00a0heart failure\u00a0in patients with type 2 diabetes mellitus: a retrospective\u00a0cohort\u00a0analysis. J Am Heart Assoc. 2019;8(21):e011640. https:\/\/doi.org\/10.1161\/JAHA.118.011640.","journal-title":"J Am Heart Assoc."},{"issue":"4","key":"1041_CR123","doi-asserted-by":"publisher","first-page":"e005379","DOI":"10.1161\/jaha.116.005379","volume":"6","author":"CL Roumie","year":"2017","unstructured":"Roumie CL, Min JY, D\u2019Agostino McGowan L, Presley C, Grijalva CG, Hackstadt AJ, Hung AM, Greevy RA, Elasy T, Griffin MR. Comparative safety of sulfonylurea and\u00a0metformin\u00a0monotherapy on the risk of\u00a0heart failure: a\u00a0cohort\u00a0study. J Am Heart Assoc. 2017;6(4):e005379. https:\/\/doi.org\/10.1161\/jaha.116.005379.","journal-title":"J Am Heart Assoc."},{"key":"1041_CR124","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ijcard.2011.10.141","volume":"166","author":"SP Romero","year":"2013","unstructured":"Romero SP, Andrey JL, Garcia-Egido A, Escobar MA, Perez V, Corzo R, Garcia-Domiguez GJ, Gomez F. Metformin\u00a0therapy and prognosis of patients with\u00a0heart failure\u00a0and new-onset diabetes mellitus. A propensity-matched study in the community. Int J Cardiol. 2013;166:404\u201312.","journal-title":"Int J Cardiol"},{"issue":"1","key":"1041_CR125","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-019-0972-4","volume":"18","author":"DI Bromage","year":"2019","unstructured":"Bromage DI, Godec TR, Pujades-Rodriguez M, Gonzalez-Izquierdo A, Denaxas S, Hemingway H, Yellon DM. Metformin\u00a0use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study. Cardiovasc Diabetol. 2019;18(1):168. https:\/\/doi.org\/10.1186\/s12933-019-0972-4.","journal-title":"Cardiovasc Diabetol."},{"key":"1041_CR126","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ahj.2018.05.016","volume":"203","author":"SV Arnold","year":"2018","unstructured":"Arnold SV, Echouffo-Tcheugui JB, Lam CSP, Inzucchi SE, Tang F, McGuire DK, Goyal A, Maddox TM, Sperling LS, Fonarow GC, Masoudi FA, Kosiborod M. Patterns of glucose-lowering medication use in patients with type 2 diabetes and heart failure. Insights from the Diabetes Collaborative Registry (DCR). Am Heart J. 2018;203:25\u20139.","journal-title":"Am Heart J"},{"key":"1041_CR127","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.diabres.2017.12.011","volume":"136","author":"M Packer","year":"2018","unstructured":"Packer M. Is\u00a0metformin\u00a0beneficial for heart failure in patients with type 2 diabetes? Diabetes Res Clin Pract. 2018;136:168\u201370.","journal-title":"Diabetes Res Clin Pract"},{"key":"1041_CR128","doi-asserted-by":"publisher","first-page":"E885","DOI":"10.1152\/ajpendo.00215.2014","volume":"307","author":"MA Wijngaarden","year":"2014","unstructured":"Wijngaarden MA, Bakker LE, van der Zon GC, \u2018t Hoen PA, van Dijk KW, Jazet IM, Pijl H, Guigas B. Regulation of skeletal muscle energy\/nutrient-sensing pathways during metabolic adaptation to fasting in healthy humans. Am J Physiol Endocrinol Metab. 2014;307:E885\u201395.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1041_CR129","doi-asserted-by":"publisher","first-page":"E190","DOI":"10.1152\/ajpendo.00207.2011","volume":"302","author":"MH Vendelbo","year":"2012","unstructured":"Vendelbo MH, Clasen BF, Treebak JT, M\u00f8ller L, Krusenstjerna-Hafstr\u00f8m T, Madsen M, Nielsen TS, St\u00f8dkilde-J\u00f8rgensen H, Pedersen SB, J\u00f8rgensen JO, Goodyear LJ, Wojtaszewski JF, M\u00f8ller N, Jessen N. Insulin resistance after a 72-h fast is associated with impaired AS160 phosphorylation and accumulation of lipid and glycogen in human skeletal muscle. Am J Physiol Endocrinol Metab. 2012;302:E190\u2013200.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1041_CR130","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","volume":"26","author":"Z Gerhart-Hines","year":"2007","unstructured":"Gerhart-Hines Z, Rodgers JT, Bare O, Lerin C, Kim SH, Mostoslavsky R, Alt FW, Wu Z, Puigserver P. Metabolic control of muscle mitochondrial function and\u00a0fatty acid oxidation\u00a0through\u00a0SIRT1\/PGC-1alpha. EMBO J. 2007;26:1913\u201323.","journal-title":"EMBO J"},{"key":"1041_CR131","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1126\/science.1099196","volume":"305","author":"HY Cohen","year":"2004","unstructured":"Cohen HY, Miller C, Bitterman KJ, Wall NR, Hekking B, Kessler B, Howitz KT, Gorospe M, de Cabo R, Sinclair DA. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science. 2004;305:390\u20132.","journal-title":"Science"},{"issue":"10","key":"1041_CR132","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3389\/fnmol.2017.00377","volume":"14","author":"M Elamin","year":"2017","unstructured":"Elamin M, Ruskin DN, Masino SA, Sacchetti P. Ketone-based metabolic therapy: is increased NAD+\u2009a primary mechanism? Front Mol Neurosci. 2017;14(10):377. https:\/\/doi.org\/10.3389\/fnmol.2017.00377.","journal-title":"Front Mol Neurosci."},{"key":"1041_CR133","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.mehy.2015.08.002","volume":"85","author":"MF McCarty","year":"2015","unstructured":"McCarty MF, DiNicolantonio JJ, O\u2019Keefe JH. Ketosis may promote brain macroautophagy by activating\u00a0Sirt1\u00a0and hypoxia-inducible factor-1. Med Hypotheses. 2015;85:631\u20139.","journal-title":"Med Hypotheses"},{"key":"1041_CR134","doi-asserted-by":"publisher","first-page":"20423","DOI":"10.1074\/jbc.M111.235044","volume":"286","author":"A Vil\u00e0-Brau","year":"2011","unstructured":"Vil\u00e0-Brau A, De Sousa-Coelho AL, Mayordomo C, Haro D, Marrero PF. Human HMGCS2 regulates mitochondrial\u00a0fatty acid\u00a0oxidation and FGF21 expression in HepG2 cell line. J Biol Chem. 2011;286:20423\u201330.","journal-title":"J Biol Chem"},{"key":"1041_CR135","doi-asserted-by":"publisher","first-page":"32182","DOI":"10.1074\/jbc.M110.134890","volume":"285","author":"JM Lee","year":"2010","unstructured":"Lee JM, Seo WY, Song KH, Chanda D, Kim YD, Kim DK, Lee MW, Ryu D, Kim YH, Noh JR, Lee CH, Chiang JY, Koo SH, Choi HS. AMPK-dependent repression of hepatic\u00a0gluconeogenesis\u00a0via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner. J Biol Chem. 2010;285:32182\u201391.","journal-title":"J Biol Chem"},{"issue":"9","key":"1041_CR136","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3389\/fendo.2018.00802","volume":"24","author":"X Zhang","year":"2019","unstructured":"Zhang X, Yang S, Chen J, Su Z. Unraveling the regulation of hepatic\u00a0gluconeogenesis. Front Endocrinol (Lausanne). 2019;24(9):802. https:\/\/doi.org\/10.3389\/fendo.2018.00802(eCollection 2018).","journal-title":"Front Endocrinol (Lausanne)."},{"key":"1041_CR137","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/hmg\/ddr089","volume":"20","author":"J Bastin","year":"2011","unstructured":"Bastin J, Lopes-Costa A, Djouadi F. Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human\u00a0fatty acid oxidation-deficient fibroblasts. Hum Mol Genet. 2011;20:2048\u201357.","journal-title":"Hum Mol Genet"},{"key":"1041_CR138","doi-asserted-by":"publisher","first-page":"25758","DOI":"10.1074\/jbc.M112.362343","volume":"287","author":"TF Liu","year":"2012","unstructured":"Liu TF, Vachharajani VT, Yoza BK, McCall CE. NAD+\u2009-dependent\u00a0sirtuin 1\u00a0and 6 proteins coordinate a switch from glucose to\u00a0fatty acid oxidation\u00a0during the acute inflammatory response. J Biol Chem. 2012;287:25758\u201369.","journal-title":"J Biol Chem"},{"key":"1041_CR139","doi-asserted-by":"publisher","first-page":"635","DOI":"10.18632\/aging.100339","volume":"3","author":"MD Hirschey","year":"2011","unstructured":"Hirschey MD, Shimazu T, Capra JA, Pollard KS, Verdin E. SIRT1\u00a0and SIRT3 deacetylate homologous substrates: AceCS1,2 and HMGCS1,2. Aging. 2011;3:635\u201342.","journal-title":"Aging"},{"key":"1041_CR140","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/eurheartj\/ehv728","volume":"37","author":"D Fitchett","year":"2016","unstructured":"Fitchett D, Zinman B, Wanner C, Lachin JM, Hantel S, Salsali A, Johansen OE, Woerle HJ, Broedl UC, Inzucchi SE, EMPA-REG OUTCOME trial investigators. Heart failure\u00a0outcomes with\u00a0empagliflozin\u00a0in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME trial. Eur Heart J. 2016;37:1526\u201334.","journal-title":"Eur Heart J"},{"key":"1041_CR141","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1210\/en.2007-1326","volume":"149","author":"C S\u00e9galen","year":"2008","unstructured":"S\u00e9galen C, Longnus SL, Baetz D, Counillon L, Van Obberghen E. 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside reduces glucose uptake via the inhibition of Na+\/H+\u2009exchanger 1 in isolated rat ventricular\u00a0cardiomyocytes. Endocrinology. 2008;149:1490\u20138.","journal-title":"Endocrinology"},{"issue":"Suppl 3","key":"1041_CR142","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2362.2005.01525.x","volume":"35","author":"KU Eckardt","year":"2005","unstructured":"Eckardt KU, Kurtz A. Regulation of\u00a0erythropoietin\u00a0production. Eur J Clin Invest. 2005;35(Suppl 3):13\u20139.","journal-title":"Eur J Clin Invest"},{"key":"1041_CR143","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.119.044235","author":"CD Mazer","year":"2019","unstructured":"Mazer CD, Hare GMT, Connelly PW, Gilbert RE, Shehata N, Quan A, Teoh H, Leiter LA, Zinman B, J\u00fcni P, Zuo F, Mistry N, Thorpe KE, Goldenberg RM, Yan AT, Connelly KA, Verma S. Effect of empagliflozin on\u00a0erythropoietin\u00a0levels, iron stores and red blood cell morphology in patients with type 2 diabetes and coronary artery disease. Circulation. 2019. https:\/\/doi.org\/10.1161\/circulationaha.119.044235(Epub ahead of print).","journal-title":"Circulation"},{"key":"1041_CR144","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2337\/dc17-1096","volume":"41","author":"SE Inzucchi","year":"2018","unstructured":"Inzucchi SE, Zinman B, Fitchett D, Wanner C, Ferrannini E, Schumacher M, Schmoor C, Ohneberg K, Johansen OE, George JT, Hantel S, Bluhmki E, Lachin JM. How does\u00a0empagliflozin\u00a0reduce cardiovascular mortality? Insights from a\u00a0mediation\u00a0analysis\u00a0of the EMPA-REG OUTCOME trial. Diabetes Care. 2018;41:356\u201363.","journal-title":"Diabetes Care"},{"key":"1041_CR145","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jchf.2019.08.004","volume":"8","author":"JW Li","year":"2020","unstructured":"Li JW, Woodward M, Perkovic V, Figtree GA, Heerspink HJL, Mahaffey KW, de Zeeuw D, Vercruysse F, Shaw W, Matthews DR, Neal B. Mediators of the effects of canagliflozin on heart\u00a0failure in patients with type 2 diabetes. JACC Heart Fail. 2020;8:57\u201366.","journal-title":"JACC Heart Fail."},{"key":"1041_CR146","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/bdd.1909","volume":"35","author":"Y Chino","year":"2014","unstructured":"Chino Y, Samukawa Y, Sakai S, Nakai Y, Yamaguchi J, Nakanishi T, Tamai I. SGLT2 inhibitor lowers serum\u00a0uric acid\u00a0through alteration of\u00a0uric acid\u00a0transport activity in renal tubule by increased\u00a0glycosuria. Biopharm Drug Dispos. 2014;35:391\u2013404.","journal-title":"Biopharm Drug Dispos"},{"key":"1041_CR147","doi-asserted-by":"publisher","first-page":"F173","DOI":"10.1152\/ajprenal.00462.2018","volume":"316","author":"A Novikov","year":"2019","unstructured":"Novikov A, Fu Y, Huang W, Freeman B, Patel R, van Ginkel C, Koepsell H, Busslinger M, Onishi A, Nespoux J, Vallon V. SGLT2\u00a0inhibition and renal\u00a0urate\u00a0excretion: role of luminal glucose, GLUT9, and URAT1. Am J Physiol Renal Physiol. 2019;316:F173\u201385.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2019","key":"1041_CR148","doi-asserted-by":"publisher","first-page":"9246138","DOI":"10.1155\/2019\/9246138","volume":"9","author":"E Romuk","year":"2019","unstructured":"Romuk E, Wojciechowska C, Jache\u0107 W, Zem\u0142a-Woszek A, Momot A, Buczkowska M, Rozentryt P. Malondialdehyde and\u00a0uric acid\u00a0as predictors of adverse outcome in\u00a0patients\u00a0with chronic\u00a0heart\u00a0failure. Oxid Med Cell Longev. 2019;9(2019):9246138. https:\/\/doi.org\/10.1155\/2019\/9246138.","journal-title":"Oxid Med Cell Longev."},{"key":"1041_CR149","doi-asserted-by":"publisher","first-page":"147040","DOI":"10.1155\/2014\/147040","volume":"2014","author":"C Wojciechowska","year":"2014","unstructured":"Wojciechowska C, Romuk E, Tomasik A, Skrzep-Poloczek B, Nowalany-Kozielska E, Birkner E, Jache\u0107 W. Oxidative stress\u00a0markers and C-reactive protein are related to severity of\u00a0heart failure\u00a0in patients with dilated cardio-myopathy. Mediators Inflamm. 2014;2014:147040. https:\/\/doi.org\/10.1155\/2014\/147040.","journal-title":"Mediators Inflamm"},{"key":"1041_CR150","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1253\/circj.70.1006","volume":"70","author":"H Sakai","year":"2006","unstructured":"Sakai H, Tsutamoto T, Tsutsui T, Tanaka T, Ishikawa C, Horie M. Serum level of\u00a0uric acid, partly secreted from the failing heart, is a prognostic marker in patients with congestive\u00a0heart failure. Circ J. 2006;70:1006\u201311.","journal-title":"Circ J"},{"key":"1041_CR151","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1111\/j.1464-5491.2005.01630.x","volume":"22","author":"UR Kuppusamy","year":"2005","unstructured":"Kuppusamy UR, Indran M, Rokiah P. Glycaemic control in relation to\u00a0xanthine oxidase\u00a0and antioxidant indices in Malaysian Type 2\u00a0diabetes\u00a0patients. Diabet Med. 2005;22:1343\u20136.","journal-title":"Diabet Med"},{"key":"1041_CR152","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","volume":"134","author":"CF Lee","year":"2016","unstructured":"Lee CF, Chavez JD, Garcia-Menendez L, et al. Normalization of\u00a0NAD\u2009+\u2009redox balance as a therapy for\u00a0heart failure. Circulation. 2016;134:883\u201394.","journal-title":"Circulation"},{"key":"1041_CR153","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/10715769809065801","volume":"28","author":"Z Zhang","year":"1998","unstructured":"Zhang Z, Blake DR, Stevens CR, et al. A reappraisal of\u00a0xanthine dehydrogenase\u00a0and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor. Free Radic Res. 1998;28:151\u201364.","journal-title":"Free Radic Res."},{"key":"1041_CR154","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/JOE-11-0355","volume":"213","author":"M Lappas","year":"2012","unstructured":"Lappas M, Andrikopoulos S, Permezel M. Hypoxanthine-xanthine oxidase\u00a0down-regulates GLUT1 transcription via SIRT1 resulting in decreased glucose uptake in human placenta. J Endocrinol. 2012;213:49\u201357.","journal-title":"J Endocrinol"},{"key":"1041_CR155","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10157-019-01804-8","volume":"24","author":"H Kim","year":"2020","unstructured":"Kim H, Baek CH, Chang JW, Yang WS, Lee SK. Febuxostat, a novel inhibitor of\u00a0xanthine oxidase, reduces ER stress through upregulation of\u00a0SIRT1-AMPK-HO-1\/thioredoxin expression. Clin Exp Nephrol. 2020;24:205\u201315.","journal-title":"Clin Exp Nephrol"},{"key":"1041_CR156","first-page":"648","volume":"16","author":"H A\u015fc\u0131","year":"2016","unstructured":"A\u015fc\u0131 H, Sayg\u0131n M, Ye\u015filot \u015e, Topsakal \u015e, Cankara FN, \u00d6zmen \u00d6, Savran M. Protective effects of aspirin and vitamin C against corn syrup consumption-induced cardiac damage through\u00a0sirtuin-1\u00a0and HIF-1\u03b1 pathway. Anatol J Cardiol. 2016;16:648\u201354.","journal-title":"Anatol J Cardiol."},{"key":"1041_CR157","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/gerona\/glq080","volume":"65","author":"MJ Ryan","year":"2010","unstructured":"Ryan MJ, Jackson JR, Hao Y, Williamson CL, Dabkowski ER, Hollander JM, Alway SE. Suppression of oxidative stress by\u00a0resveratrol\u00a0after isometric contractions in gastrocnemius muscles of aged mice. J Gerontol A Biol Sci Med Sci. 2010;65:815\u201331.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1041_CR158","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cbdv.200890059","volume":"5","author":"XF Huang","year":"2008","unstructured":"Huang XF, Li HQ, Shi L, Xue JY, Ruan BF, Zhu HL. Synthesis of\u00a0resveratrol\u00a0analogues, and evaluation of their cytotoxic and\u00a0xanthine oxidase\u00a0inhibitory activities. Chem Biodivers. 2008;5:636\u201342.","journal-title":"Chem Biodivers"},{"key":"1041_CR159","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s12020-016-0896-7","volume":"53","author":"J Wang","year":"2016","unstructured":"Wang J, Zhu XX, Liu L, Xue Y, Yang X, Zou HJ. SIRT1\u00a0prevents hyperuricemia via the PGC-1\u03b1\/PPAR\u03b3-ABCG2 pathway. Endocrine. 2016;53:443\u201352.","journal-title":"Endocrine"},{"key":"1041_CR160","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/dom.13101","volume":"20","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Xu L, Tian D, Xia P, Zheng H, Wang L, Chen L. Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: a meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2018;20:458\u201362.","journal-title":"Diabetes Obes Metab"},{"key":"1041_CR161","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1139\/cjpp-2016-0567","volume":"95","author":"R Nistala","year":"2017","unstructured":"Nistala R, Raja A, Pulakat L. mTORC1 inhibitors rapamycin and\u00a0metformin\u00a0affect cardiovascular markers differentially in ZDF rats. Can J Physiol Pharmacol. 2017;95:281\u20137.","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01041-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-020-01041-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-020-01041-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T23:20:20Z","timestamp":1620861620000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-020-01041-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,13]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1041"],"URL":"https:\/\/doi.org\/10.1186\/s12933-020-01041-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,13]]},"assertion":[{"value":"31 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. All authors agree to publication. No permissions are needed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Packer has consulted for Abbvie, Actavis, Akcea, Amgen, AstraZeneca, Boehringer Ingelheim, Cardiorentis, Daiichi Sankyo, Johnson & Johnson, NovoNordisk, Pfizer, Relypsa, Sanofi, Synthetic Biologics and Theravance.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}